Experts’ consensus on intraoperative radiotherapy for pancreatic cancer

Ye‐Xiong Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Chengfeng Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qinfu Feng(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingtai Chen(Shanghai Jiao Tong University), Susheng Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianwei Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Wang(NYU Langone Health), Guang Li(First Hospital of China Medical University), Lei Zheng(Fujian Medical University), Jing Jin(The University of Sydney), Zhihui Zhang(Tianjin Medical University General Hospital), Shengping Li(Sun Yat-sen University), Fei Li(Xiamen Medical College), Xu Che(Stomatology Hospital), Rufu Chen(Guangdong Academy of Medical Sciences), Xiuhong Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Menghua Dai(Peking Union Medical College Hospital)
Cancer Letters
February 14, 2019
10.1016/j.canlet.2019.01.038
Cited by 22

Related Papers

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
|Cell|2016|1.1k
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
|Nature Reviews Neurology|2020|504
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436